NanoGroup S.A. (NNG.WA)

PLN 2.37

(-1.25%)

Long Term Debt Summary of NanoGroup S.A.

  • NanoGroup S.A.'s latest annual long term debt in 2023 was - PLN , down 0.0% from previous year.
  • NanoGroup S.A.'s latest quarterly long term debt in 2024 Q2 was - PLN , down 0.0% from previous quarter.
  • NanoGroup S.A. reported annual long term debt of - PLN in 2022, down -100.0% from previous year.
  • NanoGroup S.A. reported annual long term debt of 139.17 Thousand PLN in 2021, down -51.22% from previous year.
  • NanoGroup S.A. reported quarterly long term debt of - PLN for 2024 Q1, down 0.0% from previous quarter.
  • NanoGroup S.A. reported quarterly long term debt of - PLN for 2023 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of NanoGroup S.A. (2023 - 2014)

Historical Annual Long Term Debt of NanoGroup S.A. (2023 - 2014)

Year Long Term Debt Long Term Debt Growth
2023 - PLN 0.0%
2022 - PLN -100.0%
2021 139.17 Thousand PLN -51.22%
2020 285.31 Thousand PLN -33.76%
2019 430.71 Thousand PLN 104.0%
2018 -10.77 Million PLN 0.0%
2017 - PLN 0.0%
2016 - PLN 0.0%
2015 - PLN -100.0%
2014 1.3 Million PLN 0.0%

Peer Long Term Debt Comparison of NanoGroup S.A.

Name Long Term Debt Long Term Debt Difference
Bioceltix S.A. 76.33 Thousand PLN 100.0%
BIOTON S.A. 12.67 Million PLN 100.0%
Captor Therapeutics Spolka Akcyjna 1.24 Million PLN 100.0%
Mabion S.A. 2.94 Million PLN 100.0%
Molecure S.A. 4.97 Million PLN 100.0%
Pharmena S.A. 114 Thousand PLN 100.0%
Poltreg S.A. 7.8 Million PLN 100.0%
Pure Biologics Spólka Akcyjna 12.85 Million PLN 100.0%
Ryvu Therapeutics S.A. 365 Thousand PLN 100.0%
Synthaverse S.A. 61.2 Million PLN 100.0%
Urteste S.A. 312 Thousand PLN 100.0%